NCT04906993 2025-09-09Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical CancerJiangsu HengRui Medicine Co., Ltd.Phase 3 Active not recruiting443 enrolled
NCT06986057 2025-05-22Iparomlimab and Tuvonralimab Combined With Platinum-Based Chemotherapy for Neoadjuvant Treatment of Cervical CancerShandong Tumor HospitalPhase 2 Not yet recruiting28 enrolled